RSS

University of Bristol

Novo Nordisk, global healthcare company, has acquired all of the shares of a University of Bristol spin-out company — Ziylo — giving it full rights to a glucose blinding molecule platform to develop glucose responsive insulins. more

News

Grants totalling £12 million have been awarded to four UK universities in support of interdisciplinary research into the biological, social, cultural and economic drivers behind the development of antimicrobial resistance (AMR) more

News

Debilitating side effects associated with prescription medication for some of today’s most common conditions could be eradicated if they mimicked the body’s natural hormone secretion cycles, a new report has said. more

News